loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 20177 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Baxter Healthcare Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 BAXTER HLTHCARE (1)

    filter

    01 INJECTABLE;INJECTION (1)

    filter

    01 DISCN (1)

    filter

    01 TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    INJECTABLE; INJECT...
    3.5%;51MG/100ML;13...
    1995-10-23
    20177
    TRAVASOL 3.5% SULF...
    DISCN
    No
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 20177

    Looking for FDA Orange Book APPLICATION 20177 1

    19

    Baxter Healthcare Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE, with a corresponding application number 20177.

    Regulatory Information DISCN

    With a dosage strength 3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100ML

    Dosage Form Route INJECTABLE; INJECTION

    Reference Listed Drug No

    Approved since 1995-10-23

    Post Enquiry
    POST ENQUIRY